Shire Nabs Advanced BioHealing Just Prior To Planned IPO
This article was originally published in The Gray Sheet
Executive Summary
Just before its planned debut on the New York Stock Exchange, wound healing device maker Advanced BioHealing Inc. instead agreed to a $750 million buyout offer May 17 from drug maker Shire PLC, which has a history of using acquisitions to jump quickly into new lines of business.
You may also be interested in...
New Products In Brief
Debuts include OptiMedica’s Catalys laser system for cataract surgery, Quest’s cervical cancer test and NeuroSigma’s Monarch external trigeminal nerve stimulation (eTNS) system for epilepsy and major depressive disorder.
Sanuwave On Track To Submit dermaPACE PMA By June 30
Sanuwave Health says it is on track to wrap up a PMA submission by the end of June for its dermaPACE wound care device, which treats chronic diabetic foot ulcers with high-energy acoustic pressure waves.
Sanuwave On Track To Submit dermaPACE PMA By June 30
Sanuwave Health says it is on track to wrap up a PMA submission by the end of June for its dermaPACE wound care device, which treats chronic diabetic foot ulcers with high-energy acoustic pressure waves.